Literature DB >> 14986086

5-Lipoxygenase and leukotriene A4 hydrolase expression in primary nephrotic syndrome.

A Bakr1, S Hawas, S Slem, A Abdel Moniem, T Ghatab, M Tawfik.   

Abstract

Gene expression of 5-lipoxygenase (5-LO) and leukotriene A(4) (LTA(4)) hydrolase was analyzed in the peripheral blood of 48 children with active primary nephrotic syndrome (PNS) (group I), 27 children with PNS in remission (group II), and 20 controls. Group I included 34 patients with steroid-sensitive PNS (SSNS) and 14 patients with steroid-resistant PNS (SRNS). Total RNA purified from peripheral blood mononuclear (PBMN) cells was reverse transcribed into cDNA and amplified with specific primers in the polymerase chain reaction. All group I patients and none of the controls expressed 5-LO and LTA(4 )hydrolase. Of group II children, 22.2% expressed 5-LO, while 51.9% expressed LTA(4 )hydrolase. Among group I patients there was a significant positive correlation between the degree of proteinuria and the expression of 5-LO ( r=0.27, P=0.03) and LTA(4 )hydrolase ( r=0.44, P=0.001). There was no difference in the degree of expression of both enzymes between SSNS and SRNS patients. In conclusion, leukotrienes may play a role in the pathogenesis of PNS in children, but they do not participate in the response of these patients to steroids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986086     DOI: 10.1007/s00467-003-1399-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  23 in total

Review 1.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

Review 2.  Arachidonic acid metabolites in glomerular immune injury.

Authors:  K F Badr
Journal:  Semin Nephrol       Date:  1991-05       Impact factor: 5.299

Review 3.  Glomerulonephritis: roles for lipoxygenase pathways in pathophysiology and therapy.

Authors:  K F Badr
Journal:  Curr Opin Nephrol Hypertens       Date:  1997-03       Impact factor: 2.894

Review 4.  Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

Authors:  C N Serhan
Journal:  Prostaglandins       Date:  1997-02

5.  Inhibition of 5-lipoxygenase activating protein decreases proteinuria in diabetic rats.

Authors:  Jose M Valdivielso; Angel Montero; Kamal F Badr; Karen A Munger
Journal:  J Nephrol       Date:  2003 Jan-Feb       Impact factor: 3.902

6.  Adhesion promotes transcellular leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: inhibition by antibodies against CD18 and L-selectin.

Authors:  H R Brady; C N Serhan
Journal:  Biochem Biophys Res Commun       Date:  1992-08-14       Impact factor: 3.575

7.  Expression of 5-lipoxygenase and 5-lipoxygenase activation protein in glomerulonephritis.

Authors:  A Rifai; H Sakai; M Yagame
Journal:  Kidney Int Suppl       Date:  1993-01       Impact factor: 10.545

Review 8.  The role of leukotrienes in inflammation.

Authors:  W R Henderson
Journal:  Ann Intern Med       Date:  1994-11-01       Impact factor: 25.391

9.  Increased leukotriene B4 synthesis in immune injured rat glomeruli.

Authors:  M A Rahman; M Nakazawa; S N Emancipator; M J Dunn
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  2 in total

1.  Autosomal Recessive Congenital Ichthyosis and Steroid-Resistant Nephrotic Syndrome due to Homozygous Mutation in the ALOX12B gene: A Novel Association with Review of Literature.

Authors:  Lesa Dawman; Anit Kaur; Ritambhra Nada; Soumalya Chakraborty; Sanjeev Handa; Indar Kumar Sharawat; Karalanglin Tiewsoh
Journal:  J Pediatr Genet       Date:  2020-10-19

2.  Montelukast as an add-on treatment in steroid dependant nephrotic syndrome, randomised-controlled trial.

Authors:  Magdy Mohamed Zedan; Ahmed El-Refaey; Hosam Zaghloul; Mohamed E A Abdelrahim; Amal Osman; Mohamed M Zedan; Nashwa Eltantawy
Journal:  J Nephrol       Date:  2016-03-31       Impact factor: 3.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.